DDX5 and myeloproliferative neoplasm: Although the underlying molecular mechanisms have yet to be clarified, the activation of STAT5, a downstream signaling molecule of the JAK2V617F mutant, was required for the stabilization of the DDX5 protein in MPN cells [55].